ImmuneOnco (宜明昂科) Pre-IPO: Clinical Numbers Are yet to Be Convincing
We look at ImmuneOnco, a biotech company seeking a listing in Hong Kong. The company is focused on CD47 products. Given the clinical data presented...
426 Views
ImmuneOnco Biopharmaceuticals (IOB HK) Pre-IPO: A Potentially Differentiated Oncology Portfolio
The company intends to list its shares on HK stock exchange. Investors, with high-risk appetite can consider this IPO for long-term investment due...
454 Views